Some biological properties of flurbiprofen, an anti-inflammatory, analgesic and antipyretic agent
- PMID: 1081878
Some biological properties of flurbiprofen, an anti-inflammatory, analgesic and antipyretic agent
Abstract
2-(2-Fluoro-4-biphenyl)propionic acid (flurbiprofen) possesses peripheral analgesic, anti-inflammatory and antipyretic properties. It does not possess glucocorticoid or adrenocortical-stimulating properties. It is a highly potent agent which in acute pharmacological test systems produced a significant pharmacological effect in single oral doses varying from 0.04 to 0.47 mg/kg. The peak plasma concentrations attained after these doses were generally of the order of 1 to 3 mug/ml. Doses of 0.33 mg/kg/day, which gave peak plasma concentrations of 0.6 mug/ml, produced a significant inhibition of rat adjuvant arthritis, both developing and established. The very shallow dose-response curves for flurbiprofen compared with acetylsalicylic acid, especially in the mouse and the rat test systems, are not due to an unreliable or abnormal absorption, which suggests that in these species the mode of action of flurbiprofen is not identical with that of acetylsalicylic acid.
Similar articles
-
Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.Drugs. 1979 Dec;18(6):417-38. doi: 10.2165/00003495-197918060-00001. Drugs. 1979. PMID: 391529 Review.
-
The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.Arzneimittelforschung. 1983;33(11):1555-69. Arzneimittelforschung. 1983. PMID: 6607053
-
[Anti-inflammatory action of 2-(2-fluoro-4-biphenylyl) propionic acid (flubiprofen].Nihon Yakurigaku Zasshi. 1975 Sep;71(6):573-83. Nihon Yakurigaku Zasshi. 1975. PMID: 1238328 Japanese.
-
The pharmacological properties of fenbufen. A review.Arzneimittelforschung. 1980;30(4A):716-21. Arzneimittelforschung. 1980. PMID: 7002162 Review.
-
Chemistry and pharmacology of naproxen.Arzneimittelforschung. 1975 Feb;25(2A):278-81. Arzneimittelforschung. 1975. PMID: 1173774
Cited by
-
The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia.Agents Actions. 1987 Feb;20(1-2):50-60. doi: 10.1007/BF01965625. Agents Actions. 1987. PMID: 3554912 Review.
-
Predictability of the clinical potency of NSAIDs from the preclinical pharmacodynamics in rats.Inflamm Res. 1996 Nov;45(11):531-40. doi: 10.1007/BF02342223. Inflamm Res. 1996. PMID: 8951503
-
The effect oa a new anti-inflammatory drug, flurbiprofen, on the respiratory, haemodynamic and metabolic responses to E. coli endotoxin shock in the cat.Br J Pharmacol. 1976 Dec;58(4):547-51. doi: 10.1111/j.1476-5381.1976.tb08622.x. Br J Pharmacol. 1976. PMID: 793668 Free PMC article.
-
Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition.Experientia. 1991 Mar 15;47(3):257-61. doi: 10.1007/BF01958153. Experientia. 1991. PMID: 2009936
-
Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.Drugs. 1979 Dec;18(6):417-38. doi: 10.2165/00003495-197918060-00001. Drugs. 1979. PMID: 391529 Review.